Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Sugita S, Enokida H, Yoshino H, Miyamoto K, et al. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer. Int J Oncol 2018 Jun 11. doi: 10.3892/ijo.2018.4435.
PMID: 29901113


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016